세계의 조영 증강 초음파 시장 : 제품별, 기술별, 공급 방식별, 이미징 기술별, 용도별, 환자 속성별, 최종 사용자별 - 예측(2025-2030년)

The Contrast Enhanced Ultrasound Market was valued at USD 2.08 billion in 2023, expected to reach USD 2.20 billion in 2024, and is projected to grow at a CAGR of 6.43%, to USD 3.21 billion by 2030.

Contrast Enhanced Ultrasound (CEUS) stands as a powerful imaging technique that enhances conventional ultrasound by employing contrast agents to improve the clarity and detail of ultrasound images. This modality holds significant importance within medical diagnostics due to its non-invasive nature, real-time imaging capabilities, absence of ionizing radiation, and improved accuracy in detecting microvascular blood flow changes. The necessity for CEUS arises primarily from its diagnostic application in detecting liver lesions, characterizing complex abdominal masses, and evaluating organ perfusion, enhancing clinical decision-making. Its end-use scope spans hospitals, clinics, and diagnostic imaging centers, where accurate diagnoses and patient safety are paramount.

Market growth for CEUS is propelled by various factors, including increasing incidences of liver disorders and cardiovascular diseases, growing awareness regarding the benefits of non-invasive diagnostic procedures, and technological advancements in ultrasound systems. The latest potential opportunity lies in the expansion of CEUS applications beyond traditional domains, such as in oncology for tumor evaluation and cardiovascular assessments for improved heart disease diagnostics. For businesses to capitalize on these opportunities, they should invest in R&D to innovate cost-effective and patient-friendly contrast agents and ultra-portable ultrasound devices.

However, the CEUS market faces limitations such as the relatively high cost of contrast agents, a shortage of trained professionals, and regulatory challenges pertaining to the approval of contrast agents in certain regions. These factors, combined with competition from alternative imaging modalities like MRI and CT, pose challenges to market growth. Innovation opportunities exist in developing AI-driven software for enhanced image analysis, miniaturization of ultrasound devices for point-of-care scenarios, and exploring CEUS applications in veterinary medicine.

Overall, the CEUS market is dynamic with significant growth potential. To remain competitive, stakeholders should prioritize technological advancements, expand application areas, and improve cost-effectiveness, ensuring broader adoption across diverse medical disciplines.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contrast Enhanced Ultrasound Market

The Contrast Enhanced Ultrasound Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic and lifestyle-related diseases
  • Increasing preference for non-invasive diagnostic procedures
• Market Restraints
  • Integration and deployment issues of CEU into existing medical infrastructure
• Market Opportunities
  • Continuous innovation in imaging technologies to improve the accuracy of contrast-enhanced ultrasound
  • High potential in personalized diagnostic protocols for more tailored patient care
• Market Challenges
  • Availability of alternative technologies for diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Contrast Enhanced Ultrasound Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contrast Enhanced Ultrasound Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contrast Enhanced Ultrasound Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contrast Enhanced Ultrasound Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contrast Enhanced Ultrasound Market

A detailed market share analysis in the Contrast Enhanced Ultrasound Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contrast Enhanced Ultrasound Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contrast Enhanced Ultrasound Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contrast Enhanced Ultrasound Market

A strategic analysis of the Contrast Enhanced Ultrasound Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contrast Enhanced Ultrasound Market, highlighting leading vendors and their innovative profiles. These include Bracco S.p.A., Bristol-Myers Squibb Company, Canon Inc., Carestream Health, Inc., Daiichi Sankyo Company, Limited, Esaote S.p.A,, FUJIFILM Corporation, GE HealthCare Technologies Inc., Hitachi, Ltd., Koninklijke Philips N.V., Lantheus Holdings, Inc., Leriva SA, Mayo Clinic, Medtronics PLC, Mobisante, Inc., nanoPET Pharma GmbH, Samsung Medison Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, TeraRecon, Inc., Toshiba Corporation, and Trivitron Healthcare Private Limited.

Market Segmentation & Coverage

This research report categorizes the Contrast Enhanced Ultrasound Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Contrast Agents and Ultrasound Machines. The Contrast Agents is further studied across Microbubble Contrast Agents and Nanoparticle-Based Contrast Agents.
• Based on Technology, market is studied across 2D Ultrasound and 3D & 4D Ultrasound.
• Based on Mode of Delivery, market is studied across Intravascular and Intravesical.
• Based on Imaging Technique, market is studied across Fixed-Point or Static and Real-Time.
• Based on Application, market is studied across Abdominal Imaging, Cardiovascular Imaging, Musculoskeletal Imaging, Obstetric & Gynecological Imaging, and Urological Imaging.
• Based on Patient Demographics, market is studied across Adult Imaging, Geriatric Imaging, and Pediatric Imaging.
• Based on End-User, market is studied across Clinics, Diagnostic Imaging Centers, Hospitals, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic and lifestyle-related diseases
    • 5.1.1.2. Increasing preference for non-invasive diagnostic procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Integration and deployment issues of CEU into existing medical infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous innovation in imaging technologies to improve the accuracy of contrast-enhanced ultrasound
    • 5.1.3.2. High potential in personalized diagnostic protocols for more tailored patient care
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative technologies for diagnosis
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging use of microbubble contrast agent due to enhanced imaging capabilities
  • 5.2.2. Application: Increasing applications of CEUS in cardiovascular imaging owing to its ability to visualize blood flow
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Contrast Enhanced Ultrasound Market, by Product

• 6.1. Introduction
• 6.2. Contrast Agents
  • 6.2.1. Microbubble Contrast Agents
  • 6.2.2. Nanoparticle-Based Contrast Agents
• 6.3. Ultrasound Machines

7. Contrast Enhanced Ultrasound Market, by Technology

• 7.1. Introduction
• 7.2. 2D Ultrasound
• 7.3. 3D & 4D Ultrasound

8. Contrast Enhanced Ultrasound Market, by Mode of Delivery

• 8.1. Introduction
• 8.2. Intravascular
• 8.3. Intravesical

9. Contrast Enhanced Ultrasound Market, by Imaging Technique

• 9.1. Introduction
• 9.2. Fixed-Point or Static
• 9.3. Real-Time

10. Contrast Enhanced Ultrasound Market, by Application

• 10.1. Introduction
• 10.2. Abdominal Imaging
• 10.3. Cardiovascular Imaging
• 10.4. Musculoskeletal Imaging
• 10.5. Obstetric & Gynecological Imaging
• 10.6. Urological Imaging

11. Contrast Enhanced Ultrasound Market, by Patient Demographics

• 11.1. Introduction
• 11.2. Adult Imaging
• 11.3. Geriatric Imaging
• 11.4. Pediatric Imaging

12. Contrast Enhanced Ultrasound Market, by End-User

• 12.1. Introduction
• 12.2. Clinics
• 12.3. Diagnostic Imaging Centers
• 12.4. Hospitals
• 12.5. Research Institutes

13. Americas Contrast Enhanced Ultrasound Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Contrast Enhanced Ultrasound Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Contrast Enhanced Ultrasound Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Collaborative Efforts of Inteleos and International Contrast Ultrasound Society to Elevate Contrast-Enhanced Ultrasound Education and Standards
  • 16.3.2. Samsung Medison and Bracco Imaging Partnered to Advance Diagnostic Ultrasound Technologies
  • 16.3.3. Koninklijke Philips N.V enhanced the application of EPIQ Elite
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bracco S.p.A.
• 2. Bristol-Myers Squibb Company
• 3. Canon Inc.
• 4. Carestream Health, Inc.
• 5. Daiichi Sankyo Company, Limited
• 6. Esaote S.p.A,
• 7. FUJIFILM Corporation
• 8. GE HealthCare Technologies Inc.
• 9. Hitachi, Ltd.
• 10. Koninklijke Philips N.V.
• 11. Lantheus Holdings, Inc.
• 12. Leriva SA
• 13. Mayo Clinic
• 14. Medtronics PLC
• 15. Mobisante, Inc.
• 16. nanoPET Pharma GmbH
• 17. Samsung Medison Co., Ltd.
• 18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 19. Siemens AG
• 20. TeraRecon, Inc.
• 21. Toshiba Corporation
• 22. Trivitron Healthcare Private Limited